Cachet Pharmaceutical Co., Ltd. (002462.SZ)
CNY 13.73
(-0.94%)
CNY 13.73
(-0.94%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.59 Billion | -163.44 Million | 913.12 Million | 1.11 Billion | 293.11 Million | -291.75 Million |
| Net Income | 376.53 Million | 468.31 Million | 601.87 Million | 590.9 Million | 659.8 Million | 570.61 Million |
| Depreciation & Amortization | 202.14 Million | 226.74 Million | 201.08 Million | 175.91 Million | 80.77 Million | 32.15 Million |
| Deferred income taxes | -31.76 Million | -34.28 Million | -3.51 Million | 261.4 Thousand | 1.62 Million | -4.28 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 569.43 Million | -1.21 Billion | -133.77 Million | -47.67 Million | -686.42 Million | -1.11 Billion |
| Other non-cash items | 245.17 Million | 357.82 Million | 243.93 Million | 395.72 Million | 238.96 Million | 222.54 Million |
| Investing Cash Flow | -185.25 Million | -175.43 Million | -257.12 Million | -293.54 Million | -318.69 Million | -41.68 Million |
| Investments in PPE | -199.29 Million | -188.53 Million | -246.95 Million | -257.98 Million | -262.53 Million | -21.66 Million |
| Acquisitions | 69.87 Million | -1.57 Million | 59.23 Million | 1.36 Million | 16.62 Million | 928.08 Thousand |
| Investment purchases | - | 1.45 | -16.24 Million | -41.98 Million | -47.56 Million | -23.83 Million |
| Sales/Maturities of investments | 3.66 Million | 10.89 Million | 2.32 Million | 979.33 Thousand | 200.33 Thousand | 2.57 Million |
| Other Investing Activities | 4.18 Million | 3.77 Million | -55.49 Million | 4.07 Million | -25.42 Million | 303.57 Thousand |
| Financing Cash Flow | -631.49 Million | -162.83 Million | -333.12 Million | -373.54 Million | 516.11 Million | 286.93 Million |
| Debt repayment | -227.64 Million | -4.61 Billion | -3.97 Billion | -4.94 Billion | -4.9 Billion | -2.93 Billion |
| Dividends payments | -90.42 Million | -107.93 Million | -96.26 Million | -116.68 Million | -37.57 Million | -223.73 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -10.94 Million | 4.73 Billion | 3.88 Billion | 4.86 Billion | 5.67 Billion | 3.44 Billion |
| Accounts receivables | -601.58 Million | -2.43 Billion | -655.14 Million | -698.97 Million | -1.12 Billion | -1.32 Billion |
| Accounts payables | 1.12 Billion | 1.76 Billion | 704.67 Million | 467.54 Million | 987.77 Million | 601.41 Million |
| Inventory | 72.78 Million | -510.7 Million | -179.78 Million | 183.5 Million | -549.97 Million | -387.76 Million |
| Other working capital | 1.09 Billion | -34.28 Million | -3.51 Million | 261.4 Thousand | 1.62 Million | -729.31 Million |
| Cash at beginning of period | 1.69 Billion | 2.2 Billion | 1.87 Billion | 1.43 Billion | 940.77 Million | 987.28 Million |
| Cash at end of period | 2.47 Billion | 1.69 Billion | 2.2 Billion | 1.87 Billion | 1.43 Billion | 940.77 Million |
| Capital Expenditure | -199.29 Million | -188.53 Million | -246.95 Million | -257.98 Million | -262.53 Million | -21.66 Million |
| Effect of forex changes on cash | - | 0.34 | -655.24 Thousand | -374.51 Thousand | 58.5 Thousand | 0.43 |
| Net cash flow / Change in cash | 778.69 Million | -501.71 Million | 322.22 Million | 447.4 Million | 490.58 Million | -46.5 Million |
| Free Cash Flow | 1.39 Billion | -351.97 Million | 666.17 Million | 856.88 Million | 30.58 Million | -313.41 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 62.75 Million | 92.68 Million | 75.53 Million | 376.53 Million | 13.19 Million | 81.37 Million |
| Depreciation & Amortization | - | 65.66 Million | 65.66 Million | 202.14 Million | 202.14 Million | -99.48 Million |
| Deferred income taxes | - | - | - | -31.76 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | 569.43 Million | -528.79 Million | 152.64 Million |
| Other non-cash items | 324.95 Million | -513.68 Million | 199.79 Million | 245.17 Million | 1.05 Billion | -134.66 Million |
| Investing Cash Flow | 270.46 Million | -50.94 Million | 8.81 Million | -185.25 Million | -166.89 Million | -2.92 Million |
| Investments in PPE | -725.02 Thousand | -6.56 Million | -2.97 Million | -199.29 Million | -185.12 Million | -3.35 Million |
| Acquisitions | 317.12 Million | 2.9 Million | 11.5 Million | 69.87 Million | 10.4 Million | 3.44 Million |
| Investment purchases | -44.93 Million | -44.8 Million | -720.11 Thousand | - | 7.05 Million | -68.04 Thousand |
| Sales/Maturities of investments | - | - | - | 3.66 Million | 3.52 Million | -3.44 Million |
| Other Investing Activities | 316.12 Million | 429.75 Thousand | 11.78 Million | 4.18 Million | 18.23 Million | 502.9 Thousand |
| Financing Cash Flow | -207.29 Million | -396.41 Million | -226.59 Million | -631.49 Million | 129.66 Million | -356.26 Million |
| Debt repayment | -59.8 Million | -233.33 Million | -173.08 Million | -227.64 Million | -515.17 Million | -1.44 Billion |
| Dividends payments | -54.68 Million | -75.84 Million | -32.25 Million | -90.42 Million | -90.42 Million | -56.48 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -92.79 Million | -25.79 Million | 13.05 Million | -10.94 Million | -325.27 Million | 1.14 Billion |
| Accounts receivables | - | - | - | -601.58 Million | -601.58 Million | 165.29 Million |
| Accounts payables | - | - | - | 1.12 Billion | - | - |
| Inventory | - | - | - | 72.78 Million | 72.78 Million | -12.65 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.6 Billion | 2.53 Billion | 2.47 Billion | 1.69 Billion | 1.77 Billion | 2.13 Billion |
| Cash at end of period | 2.05 Billion | 1.6 Billion | 2.53 Billion | 2.47 Billion | 2.47 Billion | 1.77 Billion |
| Capital Expenditure | -725.02 Thousand | -6.56 Million | -2.97 Million | -199.29 Million | -185.12 Million | -3.35 Million |
| Effect of forex changes on cash | - | - | - | - | - | -0.65 |
| Net cash flow / Change in cash | 450.87 Million | -934.01 Million | 57.55 Million | 778.69 Million | 707.06 Million | -359.33 Million |
| Free Cash Flow | 386.98 Million | -493.22 Million | 272.35 Million | 1.39 Billion | 559.16 Million | -3.49 Million |
YWRLF
HITECHGEAR
CEBR5
9539
000962
FJHL